AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $109,000 | +67.7% | 3,184 | -24.6% | 0.00% | – |
| Q2 2020 | $65,000 | +828.6% | 4,221 | +744.2% | 0.00% | – |
| Q1 2020 | $7,000 | -96.9% | 500 | -92.7% | 0.00% | – |
| Q4 2019 | $228,000 | +121.4% | 6,822 | +39.3% | 0.00% | – |
| Q3 2019 | $103,000 | +14.4% | 4,897 | +12.2% | 0.00% | – |
| Q2 2019 | $90,000 | +309.1% | 4,363 | +336.3% | 0.00% | – |
| Q1 2019 | $22,000 | -40.5% | 1,000 | -34.0% | 0.00% | – |
| Q4 2018 | $37,000 | +32.1% | 1,516 | +47.9% | 0.00% | – |
| Q3 2018 | $28,000 | -39.1% | 1,025 | -40.9% | 0.00% | – |
| Q2 2018 | $46,000 | +2.2% | 1,734 | +23.9% | 0.00% | – |
| Q1 2018 | $45,000 | -15.1% | 1,400 | 0.0% | 0.00% | – |
| Q4 2017 | $53,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |